-- Exalenz Falls Most in Month on Suspension of Sales of ID Kit in the U.S.
-- B y   R o n i t   G o o d m a n
-- 2010-10-25T11:46:57Z
-- http://www.bloomberg.com/news/2010-10-25/exalenz-falls-most-in-month-on-suspension-of-sales-of-id-kit-in-the-u-s-.html
Exalenz Bioscience Ltd.  fell the
most in almost a month as the developer of breath-testing
systems said itâ€™s suspending U.S. sales of the ID Kit II after
the U.S. Food and Drug Administration requested an accelerated
reapproval of the device.  The shares of  retreated  as much as 7.3 percent, the biggest
intraday decline since Sept. 27. The stock lost 6.8 percent to
0.954 shekel at 1:33 p.m. in Tel Aviv, giving the company a
market value 104.8 million shekels ($29 million).  The move is expected to hurt penetration into the U.S.
market, the  company said .  To contact the reporter on this story:
 Ronit Goodman  in Tel Aviv at 
 rgoodman9@bloomberg.net   To contact the editor responsible for this story:
Claudia Maedler at 
 cmaedler@bloomberg.net  